The tweet was deleted by the author.
But we saved everything 🙂.
Invivyd, Inc. is set to present a subset analysis from its CANOPY trial focusing on solid organ transplant recipients at the American Transplant Congress in Boston.
The presentation is part of broader efforts by the company and the global transplant community to share the latest advances and research developments in the field. Attendees at the event will have the opportunity to learn more about the emerging data and its implications for transplant medicine.
View post on X Loading...
Invivyd, Inc. has previously called for increased scrutiny of the connection between viral infections and cardiovascular inflammation. The company in an earlier statement said there is a need for deeper examination of viral infection roles in cardiovascular and related health risks, according to a prior report. These initiatives highlight Invivyd's continued focus on complex medical challenges affecting patient populations.